Sunbelt Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9K | Hold |
292
| – | – | ﹤0.01% | 995 |
|
|
2025
Q1 | $32.3K | Hold |
292
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q4 | $40K | Hold |
292
| – | – | ﹤0.01% | 992 |
|
|
2024
Q3 | $33.6K | Hold |
292
| – | – | ﹤0.01% | 1039 |
|
|
2024
Q2 | $40.2K | Hold |
292
| – | – | ﹤0.01% | 960 |
|
|
2024
Q1 | $40.3K | Sell |
292
-33
| -10% | -$4.55K | ﹤0.01% | 927 |
|
|
2023
Q4 | $42.8K | Hold |
325
| – | – | 0.01% | 846 |
|
|
2023
Q3 | $36.6K | Buy |
325
+83
| +34% | +$9.34K | 0.01% | 875 |
|
|
2023
Q2 | $22.8K | Hold |
242
| – | – | ﹤0.01% | 989 |
|
|
2023
Q1 | $24K | Buy |
+242
| New | +$24K | ﹤0.01% | 909 |
|
|
2020
Q2 | – | Sell |
-15,668
| Closed | -$1.53M | – | 351 |
|
|
2020
Q1 | $1.53M | Buy |
+15,668
| New | +$1.53M | 0.07% | 112 |
|